Page last updated: 2024-08-24

lamivudine and Cirrhosis, Liver

lamivudine has been researched along with Cirrhosis, Liver in 294 studies

Research

Studies (294)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	15 (5.10)	18.2507
2000's	177 (60.20)	29.6817
2010's	99 (33.67)	24.3611
2020's	3 (1.02)	2.80

Authors

Authors	Studies
Heller, T; Hercun, J; Koh, C	1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y	1
Chen, G; Chen, S; Chen, Y; Cheng, J; Ding, H; Jia, J; Jiang, W; Kong, Y; Ma, A; Ma, H; Meng, T; Ou, X; Piao, H; Shi, Y; Sun, Y; Wang, B; Wu, X; Xie, W; Xu, M; Xu, X; Xu, Y; You, H; Zhou, J	1
Ahn, SH; Chon, YE; Han, KH; Jung, KS; Kim, BK; Kim, DY; Kim, SU; Myoung, SM; Park, JY	1
Aggeletopoulou, I; Anastassiou, ED; Assimakopoulos, S; Gogos, C; Kalafateli, M; Labropoulou-Karatza, C; Mandellou, M; Taprantzi, D; Thomopoulos, K; Triantos, C; Tselekouni, P; Tsiaoussis, G; Vourli, G	1
Balkan, A; Gülşen, MT; Karaoğlan, İ; Namıduru, M; Şahin, A	1
Bair, MJ; Chen, CJ; Chen, MJ; Chu, CH; Lin, CC; Lin, ZY; Liu, CY; Shih, SC; Wang, HY; Wang, TE	1
Ahn, SH; Bae, SH; Cheong, JY; Han, KH; Jang, BK; Jeong, SW; Kim, BI; Kim, DJ; Kim, JK; Kim, MY; Kim, SG; Kim, TY; Kwon, JH; Kwon, SY; Lee, HW; Lee, JW; Myoung, S; Park, JY; Seo, YS; Tak, WY; Yim, HJ; Yoon, KT	1
Berg, T; Brodzinski, A; Fülöp, B; Jung, MC; Koukoulioti, E; Mihm, U; Sarrazin, C; Schlosser, B; Schott, E; van Bömmel, F	1
Li, T; Lin, C; Qu, Y; Wang, L; Wang, Y; Yang, B	1
Akita, T; Kumada, T; Kurisu, A; Miyake, N; Ohisa, M; Tada, T; Tanaka, J; Toyoda, H; Yasuda, S	1
Chen, Y; Gao, Z; Han, Y; Han, Z; Jia, G; Li, C; Liu, J; Luo, G; Shi, Y; Xia, L; Yin, F; Zhou, X; Zhu, J	1
Jiang, B; Li, L; Li, ZF; Song, SB; Xiu, DR; Yuan, CH; Zhang, TL	1
Chen, GC; Chen, QK; Huang, KH; Min, XH; Qing, Q; Su, H; Yu, T; Yuan, YH; Zhan, J; Zhao, LN	1
Li, YC	1
Kuroki, M	1
Chen, Y; Li, LJ; Lv, GC; Sheng, JF; Yang, YD; Yao, JM; Zheng, L	1
Bojovic, K; Delic, D; Jevtovic, D; Korac, M; Lazarevic, I; Milosevic, I; Pavlovic, IP	1
Hu, H; Hu, P; Liu, J; Peng, H; Ren, H; Tang, H; Tong, S; Yang, M; Yin, W	1
Chen, JY; Hu, JH; Jia, HY; Li, LJ; Lian, JS; Lu, YF; Xiang, DR; Yang, YD; Yu, L; Zeng, LY; Zhang, YM; Zheng, L	1
Choe, WH; Kim, JH; Ko, SY; Kwon, SY; Lee, CH	1
Su, QM; Ye, XG	1
An, J; Chung, YH; Kim, GA; Kim, KM; Lee, D; Lee, HC; Lee, YS; Lim, YS; Shim, JH; Suh, DJ	1
Ahn, SH; Hahn, KY; Han, KH; Kim, BK; Kim, DY; Kim, HC; Kim, JK; Kim, SU; Park, JY; Park, YH; Shin, SH	1
Ahn, SH; Chon, CY; Han, KH; Kim, DY; Kim, HS; Kim, MN; Kim, SU; Lee, CK; Lee, S; Park, JY	1
Deng, YR; Jin, QL; Lian, ZX; Matsuzaki, K; Moritoki, Y; Murata, M; Niu, JQ; Tsuneyama, K; Yamaguchi, T; Yoshida, K	1
Calvaruso, V; Craxì, A	1
Colombo, M; Della Corte, C; Triolo, M	1
Chanson, P; Pariente, A	1
Gu, XB; Huang, LH; Jiang, XH; Qiu, YW; Wang, D; Wu, HY; Xiao-Juan, Y; Yu, P; Zhu, YF	1
Cho, HC; Cho, JY; Choi, MS; Gwak, GY; Koh, KC; Lee, JH; Paik, SW; Paik, YH; Sohn, W; Yoo, BC	1
He, CP; Huang, LW; Ling, K; Liu, L; Wang, XM; Wen, QM; Yan, Y; Zhou, HC; Zhou, J	1
Choe, BH; Choe, HJ	1
Cainelli, F; Comparcola, D; Della Corte, C; Nobili, V; Vento, S	1
Cho, M; Choi, JY; Han, KH; Hwang, JS; Kim, BI; Kim, DJ; Lee, CK; Lee, HJ; Paik, SW; Suh, DJ; Um, SH; Woo, HY; Yoon, SK	1
Berg, T; van Bömmel, F	1
Bao, S; Cai, W; Guo, Q; Lin, L; Liu, Y; Wang, H; Wu, S; Xie, Q; Xu, B; Xu, G; Zhou, X; Zhuang, Y	1
Alcantara, L; Burak, KW; Coffin, CS; Klein, P; Myers, RP; Pang, JX; Rezaeeaval, M	1
Gao, T; Hu, P; Li, H; Li, ST; Tang, WL; Wang, H; Xie, Q; Zhao, GD; Zhou, HJ	1
Borsa-Lebas, F; Cacoub, P; Carrat, F; Fillion, A; Lacombe, K; Lopes, A; Loustaud-Ratti, V; Miailhes, P; Piroth, L; Pol, S; Rosenthal, E; Salmon, D	1
Chen, CW; Gu, EL; Ji, YY; Li, J; Ma, XY; Pan, HY; Wang, H; Wang, JL; Wang, YE; Wu, SM; Xie, Q; Xu, XW; Yao, GB; Yu, YQ; Zhang, WH	1
Chakrabarti, S; Chakravarty, R; Guha, SK; Pal, A; Saha, B; Saha, D; Sarkar, N	1
Bae, WK; Ha, SY; Jung, SK; Jwa, YJ; Kim, JW; Kim, KA; Kim, NH; Kim, YD; Lee, BH; Lee, HK; Lee, JS; Paik, WH	1
Appiah, LT; Beloukas, A; Bhagani, S; Bonnett, L; Chadwick, D; Dusheiko, G; Geretti, AM; Phillips, RO; Sarfo, FS; Stockdale, AJ	1
Casazza, G; Colombo, M; de Franchis, R; Facchetti, F; Fraquelli, M; Iavarone, M; Invernizzi, F; Jovani, M; Lampertico, P; Loglio, A; Mangia, G; Primignani, M; Viganò, M	1
Boettler, T; Thimme, R	1
Chen, JZ; Chen, SL; Du, XF; Hu, XQ; Shao, LY; Wang, J; Wang, JL; Weng, XH; Yu, YQ; Zhang, WH	1
Amani, A; Niederau, C; Thiel, A	1
Kowdley, K; Sundaram, V	1
Fu, WD; He, LX; Jiang, JN; Li, SH; Liang, P; Liu, ZH; Lu, AL; Mo, YY; Su, MH; Wang, BJ; Wu, XL; Xie, R; Zhong, SH	1
Fujioka, S; Ikeda, F; Kariyama, K; Kobashi, H; Miyatake, H; Morimoto, Y; Moriya, A; Okamoto, R; Seno, T; Takaguchi, K; Takaki, A; Takayama, H; Toshimori, J; Wada, N; Yabushita, K; Yamamoto, K; Yasunaka, T	1
Liu, Y; Qiu, P; Wang, GL; Wen, JB; Wen, P; Xiao, XZ; Xu, LF; Zhou, SF	1
Li, YH; Wu, HM; Xu, Y; Yang, J; Yang, JH; Yang, LH; Yue-Meng, W	1
Ahn, H; An, H; Choe, WH; Jung, YK; Kim, JH; Kim, SG; Kim, SU; Kim, TY; Kim, YS; Lee, JH; Seo, YS; Suh, SJ; Suk, KT; Um, SH; Yim, HJ; Yim, SY	1
Choi, MS; Gwak, GY; Kim, H; Kim, JH; Kim, K; Koh, KC; Lee, JH; Paik, SW; Paik, YH; Sinn, DH	1
Ahn, SH; Baatarkhuu, O; Han, KH; Kim, BK; Kim, DY; Kim, HS; Kim, SU; Kim, YJ; Park, JW; Park, JY; Song, KJ	1
Auh, S; Ghany, MG; Hoofnagle, JH; Koh, C; Lau, DT; Lingala, S	1
Akriviadis, E; Antoniadis, N; Cholongitas, E; Fouzas, I; Giakoustidis, D; Giouleme, O; Goulis, I; Imvrios, G; Papanikolaou, V; Vasiliadis, T	1
Cao, LL; Chen, DW; Dong, Y; Gan, Y; Wang, FC; Wang, LM; Wang, P; Xu, ZQ; Yan, JG; Zhang, HF; Zhang, M; Zhu, SS	1
Asano, M; Dohi, T; Enomoto, N; Gatanaga, H; Honda, M; Inoue, T; Kaneko, S; Kawamura, YI; Matsumoto, A; Mizokami, M; Murata, K; Nishida, N; Oka, S; Sakamoto, M; Shirasaki, T; Shuno, Y; Sugiyama, M; Tanaka, E; Yano, H	1
Makvandi, M	1
Hong, LJ; Wei, L; Ying, H; Zhang, J	1
Lee, HS	1
Li, MW; Wang, YM; Xie, SF; Yang, DH; Zhao, NF	1
Bläckberg, J; Duberg, AS; Fischler, B; Friman, S; Karlström, O; Lindh, M; Norkrans, G; Reichard, O; Sangfeldt, P; Söderström, A; Sönnerborg, A; Uhnoo, I; Weiland, O; Wejstål, R; Wiström, J	1
Biagini, M; Christensen, PB; Mössner, BK; Pedersen, C	1
Bak, YT; Byun, KS; Joo, MK; Jung, YK; Kim, JH; Kim, JS; Lee, SJ; Park, JJ; Yeon, JE; Yim, HJ	1
Brett-Smith, H; Chao, YC; Goodman, Z; Han, SH; Janssen, HL; Lee, WM; Schiff, E; Sette, H; Simsek, H; Tamez, R; Yang, J	1
Bailly, F; Beaugrand, M; Benhamou, Y; Marcellin, P; Maynard, M; Monchecourt, F; Parvaz, P; Trepo, C; Trylesinski, A; Zarski, JP; Zoulim, F	1
Choi, JW; Eun, JR; Kim, TN; Lee, HJ	1
Cai, CJ; Chen, GH; Jiang, H; Jiang, N; Li, H; Li, X; Lu, MQ; Wang, GS; Xu, C; Yang, Q; Yang, Y; Yi, HM; Yi, SH; Zhang, J; Zhang, JF	1
Canbay, A; Gerken, G; Gerlich, WH; Jochum, C; Katsounas, A; Schlaak, J	1
Calleja, JL; Peñas, B	2
Chien, RN; Liaw, YF	1
Han, T; Liang, J; Xiao, SX	1
Chen, ZY; Li, B; Li, G; Ma, YK; Wang, WT; Wen, TF; Wu, H; Xu, MQ; Yan, LN; Yang, JY; Zeng, Y; Zhao, JC	1
Bowden, S; Dore, GJ; Goodman, Z; Lewin, SR; Locarnini, S; Marks, P; Matthews, GV; Philp, FH; Sasadeusz, J; Seaberg, E; Tang, Y; Thio, CL	1
Brancaccio, G; Gaeta, GB; Nardiello, S; Precone, V; Sgrò, G; Stornaiuolo, G	1
Archimandritis, A; Avgerinos, A; Burroughs, AK; Karamanolis, D; Kougioumtzan, A; Manolakopoulos, S; Papatheodoridis, G; Raptis, S; Theodoropoulos, J; Triantos, C; Tzourmakliotis, D; Vlachogiannakos, J	1
Kao, JH; Lim, SG; Mohammed, R; Yuen, MF	1
Buti, M; Elefsiniotis, I; Esteban, R; Jardi, R; Vezali, E	1
Chen, W; Hou, JL	1
Barreiro, P; Fernández, JV; Labarga, P; Medrano, J; Soriano, V; Tuma, P; Vispo, E	1
Gong, ZJ; Hu, DF; Yang, Q	2
Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I	1
Ikeda, K	2
Berg, CL; Coffin, CS; Curry, MP; Dove, LM; Nissen, NN; Ragni, M; Regenstein, FG; Roland, ME; Sherman, KE; Stock, PG; Terrault, NA	1
Eun, JR; Kim, TN; Lee, HJ; Lee, KS	1
Liaw, YF	1
Colombo, M	1
Arisawa, T; Hayashi, R; Nomura, T; Sato, K; Shiroeda, H; Tsutsumi, M; Yamada, M	1
Marcellin, P	1
Chen, LB; Huang, LF; Zhang, LH	1
Andreone, P; Bacci, M; Burra, P; Canova, D; Cursaro, C; Fiorentino, B; Guazzini, S; Marengo, A; Marzano, A; Riili, A; Volpes, R	1
Angelico, M; Ciotti, M; Di Paolo, D; Lenci, I; Marcuccilli, F; Perno, CF; Svicher, V; Tariciotti, L; Tisone, G	1
Gogos, C; Ketikoglou, I; Manesis, EK; Manolakopoulos, S; Mimidis, K; Papatheodoridis, GV; Raptopoulou-Gigi, M; Touloumi, G; Vafiadis-Zoumbouli, I; Vasiliadis, T; Vourli, G	1
Aoki, J; Kagawa, T; Kojima, S; Koyama, A; Matsuzaki, S; Mine, T; Morino, F; Morizane, T; Nishizaki, Y; Sakuma, K; Shiozawa, H; Watanabe, N	1
Kojima, S; Mine, T; Motegi, S; Nishizaki, Y; Shiozawa, H; Watanabe, N	1
Asim, M; Das, BC; Gondal, R; Kar, P; Medhi, S; Pradeep Kumar, S	1
Andersen, ES; Christensen, PB; Frigstad, SO; Kjær, M; Konopski, Z; Krarup, H; Leutscher, P; Moessner, B; Weiland, O; Weis, N; Westin, J	1
Brown, A; Thursz, M	1
Cho, YK; Song, BC	1
Cai, JG; Hhang, ZG; Jie, ZH; Mo, GS; Shi, JP; Wu, XG; Wu, ZL; Zhang, JL	1
Aldini, R; Azzaroli, F; Buonfiglioli, F; Galli, S; Giandinoto, M; Lisotti, A; Mazzella, G; Montagnani, M; Turco, L	1
Aung, MO; Dan, YY; Fernandes, M; Lai, V; Lee, GH; Lee, YM; Lim, SG; Low, HC; Mak, B; Sutedja, D	1
Chen, T; Chen, TC; Chen, YC; Hsu, CW; Lai, MW; Liang, KH; Yeh, CT	1
Huang, LY; Li, M; Zhou, ZH	1
Lee, SS; Sherman, M	1
Ebinuma, H; Saito, H	1
Chien, RN	1
An, H; Byun, KS; Hyun, JJ; Jung, ES; Kang, HS; Kim, CD; Kim, DJ; Kim, JH; Kim, TH; Lee, HS; Ryu, HS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ; Yoon, E	1
Chow, PY; Lee, KK; Lee, VW; Li, H; Wu, DB	1
Fontana, RJ; Singal, AK	1
Shi, WQ; Tang, CL; Zhou, Z	1
Naggie, S; Sulkowski, MS	1
Chun, HJ; Jeen, YT; Jung, JY; Keum, B; Kim, CD; Kim, CH; Kim, JD; Kim, YS; Lee, HS; Ryu, HS; Seo, YS; Um, SH; Yim, HJ	1
Guyatt, G; Heels-Ansdell, D; Sun, X; Walter, SD	1
Anai, H; Honda, K; Maehara, S; Moriuchi, A; Muro, T; Seike, M; Tahara, K	1
Kim, BG; Kim, D; Kim, IK; Kim, W; Kim, YJ; Lee, HS; Yoon, JH	1
Avila, C; Bao, W; Chan, HL; Chen, YC; Choudhuri, G; Chutaputti, A; Gane, EJ; Hwang, SG; Piratvisuth, T; Prabhakar, B; Safadi, R; Sarin, SK; Suh, DJ; Tanwandee, T; Trylesinski, A; Yurdaydin, C	1
Ooi, M; Teoh, NC	1
Fu, D; Huang, Y; Ma, Y; Shen, X; Wu, H; Wu, S	1
Akbal, E; Akin, E; Alkan, E; Ataseven, H; Aygün, C; Başar, O; Baykal, O; Coban, S; Demir, M; Gülşen, MT; Ibiş, M; Koçkar, MC; Köklü, S; Köksal, AŞ; Küçükazman, M; Nadir, I; Ozdil, K; Pürnak, T; Tuna, Y; Yildirim, B; Yüksel, I; Yüksel, O	1
Chen, X; Lu, M; Shi, H; Wang, Y; Wu, C; Xu, Y	1
Wang, H; Yang, J; Zhu, X	1
Alberti, A; Brunetto, MR; Colombo, M; Craxì, A	1
Samuel, D	2
Chan, FK; Chan, HL; Chui, AK; Lau, WY; Rao, AR; Sung, JJ; Tse, CH; Wong, J; Wong, ML	1
Han, QX; Lin, XF; Lin, XY; Wang, JH	1
Cutz, E; Petric, M; Roberts, EA; Yeung, LT	1
Hanada, S; Harada, M; Kaji, R; Kumashiro, R; Sata, M	1
Cho, SW; Kyun, J; Oh, JM	1
Hong, J; Hu, Y; Liu, P; Wang, H; Zhu, D	1
Andreone, P; Bernardi, M; Biselli, M; Cursaro, C; Di Giammarino, L; Felline, F; Gramenzi, A; Lorenzini, S; Morelli, MC; Porzio, F; Sama, C; Spinucci, G	1
Aberg, JA; Crippin, J; Kessels, L; Lisker-Melman, M; Powderly, WG; Ristig, MB; Tebas, P	1
Blum, HE; Moradpour, D	1
Chung, YH; Jung, S; Lee, HC; Lee, YS; Park, HJ; Park, YH; Song, HG; Suh, DJ	1
Ahn, BM; Bae, SH; Cho, SH; Choi, JY; Han, NI; Jang, JW; Lee, CD; Lee, YS; Nam, SW; Park, DH; Park, TW; Park, YM; Yang, JM; Yoon, SK	1
Dienstag, JL; Gardner, S; Goldin, RD; Gray, DF; Hann, HW; Heathcote, EJ; Schiff, ER; Stephenson, SL; Woessner, M	1
Anschuetz, G; Baker, A; Brown, N; Everson, G; Fontana, RJ; Gardner, SD; Griffiths, D; Hann, HW; Riely, C; Schiff, ER; Wright, T	1
Aikawa, A; Akima, M; Hasegawa, A; Ishii, K; Matsumaru, K; Nonaka, H; Shinohara, M; Sumino, Y	1
Barg-Hock, H; Becker, T; Bleck, JS; Bock, CT; Böker, KH; Flemming, P; Klempnauer, J; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C	1
Chan, FK; Chan, HL; Chui, AK; Lau, WY; Rao, AR; Wong, J	1
Hadziyannis, SJ; Papatheodoridis, GV; Vassilopoulos, D	1
Fontana, RJ	2
Chen, M; Deng, W; Li, X; Ruan, L; Wang, Y; Zhou, G; Zhou, S; Zhou, Z	1
Guo, SH; Ren, H; Wang, ZY; Zeng, WQ; Zhang, DZ; Zhang, QH; Zhou, Z	1
Färkkilä, M	1
Hidaka, S; Horiike, N; Iuchi, H; Konishi, I; Michitaka, K; Miyake, T; Nakanishi, S; Onji, M; Yoshino, I	1
Maier, KP	1
De Ridder, RJ; Stronkhorst, A	1
Guo, XH; Jin, RH; Lang, ZW; Yao, GB	1
Crippin, J; Drechsler, H; Lisker-Melman, M; Ristig, M; Tebas, P	1
Avgerinos, A; Economou, M; Elefsiniotis, J; Iliadou, E; Karatapanis, S; Kougioumtzan, A; Manolakopoulos, S; Mathou, N; Triantos, C; Tzourmakliotis, D; Vlachogiannakos, J	1
Lee, HC; Suh, DJ	1
Hu, SY; Tan, XY	1
Perrillo, RP	1
Kirchner, JT; Lin, KW	1
Gentilcore, E; Marzano, A; Rizzetto, M; Smedile, A	1
Cheng, NS; Lei, BJ; Li, B; Li, XD; Liu, C; Liu, J; Lu, SC; Qin, S; Wang, XB; Wen, TF; Yan, LN; Zhang, XH; Zhao, JC; Zhao, LS	1
Lavanchy, D	1
Flemming, P; Klempnauer, J; Manns, MP; Nashan, B; Niemann, P; Rohde, P; Tillmann, HL; Tischendorf, JJ; Trautwein, C; Wiegand, J	1
Cheung, ST; Fan, ST; Lai, CL; Liu, CL; Lo, CM; Ng, IO	1
Hamada, K; Muramatsu, A; Nishioji, K; Oda, Y; Okuno, T; Shindo, M	1
Malekzadeh, R; Merat, S; Mohamadnejad, M; Nasseri-Moghaddam, S; Rakhshani, N; Sohrabpour, AA; Tavangar, SM	1
Lai, CL	1
Kanemasa, K; Maekawa, K; Minami, M; Mori, K; Okanoue, T; Sumida, Y; Tachibana, S	1
Chatur, N; Davis, JE; Owen, DA; Ramji, A; Yoshida, EM	1
Chan, HL; Chan, JY; Cheng, AS; Go, MY; Leung, WK; Liew, CT; Sung, JJ; To, KF	1
Jelev, D; Krastev, Z	1
Ahmet, D; Atilla, O; Cetin, K; Fatih, B; Güngör, B; Kadir, D; Mürüvvet, B; Sabahattin, K; Selim, B; Yilmaz, C; Zeynel, M; Ziyaettin, D	1
Al-Kadasi, H; Flisiak, I; Flisiak, R; Jaroszewicz, J; Prokopowicz, D	1
Lai, CJ; Terrault, NA	1
Andreone, P; Bernardi, M; Biselli, M; Cammà, C; Cursaro, C; Gramenzi, A; Trevisani, F	1
Komorizono, Y; Mawatari, S; Sako, K; Uchida, Y; Uomizu, K; Yamaguchi, H	1
Roche, B; Samuel, D	2
Inoue, O; Mawatari, H; Nakagawa, Y	1
Makuuchi, M; Sugawara, Y	1
Chow, WC; Dixon, JS; Farrell, G; Gray, DF; Keene, ON; Lee, CZ; Liaw, YF; Sabbat, J; Shue, K; Sung, JJ; Tanwandee, T; Tao, QM; Yuen, H	1
Du, YZ; Li, XY; Wang, JB; Wang, L; Wang, YZ; Yan, J; Zhang, ZH	1
Duncan, R; Lau, DT; Madariaga, JR; Montalbano, M; Muslu, H; Neff, GW; Nery, C; Nery, J; O'Brien, CB; Ruiz, P; Safdar, K; Schiff, ER; Shire, NJ; Tzakis, AG	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Ooga, H; Saitoh, S; Satoh, J; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A	1
Duan, XZ; Li, HW; Wang, FS; Wang, M; Xu, D; Zhuang, H	1
Bartel, J; Küppers, B; Otto, G; Otto, HF	1
Wei, L	1
Husa, P	1
Trunecka, P	1
Kuman, M; Mejzlík, V; Ondrásek, J; Pavlík, P; Studeník, P	1
Chow, DH; Lai, CL; Tsui, K; Wong, BC; Wong, DK; Yuen, JC; Yuen, MF	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Saitoh, S; Sato, J; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y	1
Carenzi, S; Colombo, M; Franchello, A; Lampertico, P; Marzano, A; Mazzaferro, V; Pulvirenti, A; Rizzetto, M; Romito, R; Salizzoni, M; Vigano, M	1
Hiraoka, A; Hirooka, M; Horiike, N; Iuchi, H; Kubo, Y; Kumagi, T; Kurose, K; Michitaka, K; Miyaoka, H; Ohmoto, M; Okada, S; Onji, M; Uehara, T; Yamamoto, K; Yamashita, Y	1
Balaska, A; Eugenidis, N; Giouleme, O; Grammatikos, N; Nikolaidis, N; Orfanou-Koumerkeridou, E; Patsiaoura, K; Tziomalos, K; Vassiliadis, T	1
Colombo, M; Donato, MF	1
Alaimo, G; Almasio, PL; Bonura, C; Cappello, M; Craxì, A; Di Marco, V; Di Stefano, R; Ferraro, D; Giglio, M; Parisi, P	1
Cañas, C; Casais, LA; Casanova, A; Chahri, N; Figueras, J; Gornals, J; Lopez, C; Taltavull, TC; Verdura, B	1
Bian, Z; Hong, Q; Shen, WS; Xie, HP; Yang, HZ; Zhang, YQ	1
Choi, MS; Koh, KC; Lee, JH; Moon, W; Moon, YM; Paik, SW; Rhee, JC; Shim, SG; Yoo, BC	1
Giles, E; Heathcote, EJ; Moskovitz, DN; Osiowy, C; Tomlinson, G	1
Changchien, CS; Lee, CM; Lu, SN; Tseng, PL; Tung, HD; Wang, JH	1
Dan, YY; Lee, YM; Lim, SG; Seet, BL; Sutedja, DS; Wai, CT	1
Liu, KH; Qin, LY; Wang, YZ; Zhang, ZH	1
Jones, DB; Katelaris, PH; Le Couteur, DG; Lin, BP; Ngu, MC; Park, GJ; Seow, F	1
Ahn, BM; Bae, SH; Cho, SH; Choi, JY; Chung, KW; Han, NI; Jang, JW; Sun, HS; Yang, JM; Yoon, SK	1
Chen, G; He, X; Huang, J; Zhu, X	1
Su, GG; Ying, MF; Zhao, NF; Zhou, Y	1
Aroldi, A; Colombo, M; Lampertico, P; Lunghi, G; Manenti, E; Ponticelli, C; Viganò, M	1
Choi, WB; Chung, YH; Kim, KM; Lee, HC; Lee, YS; Lim, YS; Suh, DJ	1
Karayiannis, P; Thomas, HC	1
Hasan, M; Miah, AR; Mohammed, S; Rahman, M; Roy, PK; Saha, SK; Sharma, YR	1
Zhang, FK	1
Chen, ML; Wen, YK	1
Boninsegna, S; Caroli, D; Fagiuoli, S; Floreani, A; Lobello, S	1
Chien, RN; Lee, CM; Liaw, YF; Yeh, CT	1
Akarca, US; Cakaloglu, Y; de Man, RA; Flink, HJ; Janssen, HL; Schalm, SW; Simon, C; So, TM; van Zonneveld, M; Zondervan, PE	1
Gong, ZJ; Jiang, XL; Mizokami, M; Xu, LM; Yuan, J; Zhou, BP	1
Haché, C; Villeneuve, JP	1
Ali, JA; Harrigan, PR; Law, JK; Savage, KJ; Sherlock, CH; Yoshida, EM	1
Abut, E; Akbayir, N; Bolukbas, C; Bolukbas, FF; Dalay, AR; Horoz, M; Ince, AT; Kendir, T; Ovunc, O; Sokmen, MH	1
Fukushima, K; Kakazu, E; Kanno, N; Kido, O; Kikuchi, K; Kogure, T; Matsuda, Y; Nagasaki, F; Nakagomi, Y; Niitsuma, H; Shimosegawa, T; Ueno, Y; Yamagiwa, Y; Yamamoto, T	1
Schiff, ER	1
Trautwein, C	1
Huang, XL; Shen, WS; Wang, FL; Wang, YZ; Xu, GL; Yang, HZ; Yang, YW	1
Zarski, JP	1
Wang, H; Xu, KC; Zhao, YL	1
Chen, SC; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MY; Huang, JF; Lee, LP; Lin, ZY; Tsai, JF; Wang, LY; Yu, ML	1
Aoyagi, T; Aoyagi, Y; Ichida, T; Nomoto, M; Ohkoshi, S; Osaki, A; Takamura, M; Terada, H; Tsubata, S; Uehara, K	1
Bloom, A; Blum, S; Loganathan, RS; Remy, P; Singu, BS; Widjaja, D; Yarlagadda, S	1
Bakulin, I; Balakirev, E; Baranova, F; Chervinko, V; Kovalchuk, A; Novozhenov, V; Stahanova, V; Stanke, A; Stenina, I; Zolotarevsky, V; Zubkin, M	1
Arora, G; Keeffe, EB	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H	1
Campbell, MS; Enriquez, AD; Reddy, KR	1
Niederau, C	1
Chang, WY; Chen, SC; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MY; Huang, JF; Lee, LP; Lin, ZY; Tsai, JF; Wang, LY; Yu, ML	1
Abiru, S; Nagaoka, S; Yatsuhashi, H	1
Fung, J; Lai, CL; Mizokami, M; Tanaka, Y; Wong, DK; Yuen, MF	1
Chen, JL; Fan, XL; Wang, L; Yan, J; Yu, H; Zhang, L	1
Ando, M; Araki, Y; Fujio, K; Fujioka, S; Higashi, T; Ikeda, H; Iwasaki, Y; Kawaguchi, M; Kobashi, H; Nishida, T; Sakaguchi, K; Shiratori, Y; Shoji, B; Takaguchi, K; Takaki, A; Yamamoto, K	1
Chow, DH; Fung, J; Lai, CL; Ngai, VW; Seto, WK; Tsui, K; Wong, BC; Wong, DK; Yuen, JC; Yuen, MF	1
Byun, KS; Choe, WH; Kim, BK; Kim, GH; Ko, SY; Kwon, SY; Lee, CH; Yeon, JE	1
Brosa, M; Buti, M; Esteban, R; Idris, BI; Richardus, JH; Schalm, SW	1
Akdogan, M; Cicek, B; Kilic, ZM; Kuran, S; Odemis, B; Oguz, D; Sasmaz, N	1
Brechot, C; Castaing, D; Dussaix, E; Fallot, G; Faria, LC; Ferrari, TC; Gigou, M; Guettier, C; Roche, B; Roque-Afonso, AM; Samuel, D; Sebagh, M	1
Ayoub, WS; Keeffe, EB	1
Chen, DS; Chen, PJ; Kao, JH; Lai, MY; Liu, CJ; Tseng, TC; Wang, CC	1
Bain, VG; Fischer, K; Gutfreund, K; Jewell, LD; Kneteman, NM; Lee, H; Ma, MM; Shapiro, JA; Tipples, G; Tyrrell, DL	1
Ben-Ari, Z; Mor, E; Shapira, Z; Shmueli, D; Tur-Kaspa, R	1
Ahmed, A; Cohn, G; Ehrenpreis, ED; Lissoos, TW; Schiano, TD; Siano, C; Zaitman, D	1
Herrero, JI; Pardo, F; Prieto, J; Quiroga, J; Riezu-Boj, JI; Sangro, B; Sola, I	1
Barber, J; Chang, TT; Chien, RN; Dent, JC; Gray, DF; Guan, R; Lai, CL; Leung, NW; Ng, KY; Stephenson, SL; Tai, DI; Wu, PC	1
Omata, M	1
Breuel, P; Horak, J; Johnson, MA	1
Bréchot, C; Carnot, F; Landau, A; Pialoux, G; Pol, S; Zylberberg, H	1
Main, J; McCarron, B; Thomas, HC	1
Ben-Ari, Z; Fraser, G; Kazetsker, A; Tur-Kaspa, R; Zemel, R	1
Esquivel, CO; Garcia, G; Imperial, JC; Keeffe, EB; Monge, H; So, SK	1
Ben-Ari, Z; Mor, E; Pappo, O; Tur-Kaspa, R; Zemel, R	1
Bechstein, WO; Budde, K; Hocher, B; Krüger, DH; Meisel, H; Neuhaus, P; Neumayer, HH; Preikschat, P; Reinke, P	1
Bárcena, R; del Campo, S; Domínguez-Antonaya, M; López-Sanromán, A; Martínez-Turnes, A; Moreno, N; Urman, J	1
Kikuchi, Y; Oka, S; Tachikawa, N; Yasuoka, A; Yoshizawa, S	1
Bilodeau, M; Condreay, LD; Fenyves, D; Heathcote, EJ; Leduc, R; Margulies, M; Peltekian, K; Pomier-Layrargues, G; Villeneuve, JP; Willems, B; Wong, F	1
Airoldi, A; Pinzello, G; Zavaglia, C	1
Ben-Ari, Z; Fainguelernt, H; Kitay-Cohen, Y; Lishner, M; Tur-Kaspa, R	1
Bass, NM; Yao, FY	1
Agarwal, SR; Guptan, RC; Hasnain, SE; Kapoor, D; Kaul, R; Kazim, SN; Raisuddin, S; Sarin, SK; Wakil, SM	1
Fontana, RJ; Lok, AS	1
McGory, R; Pruett, TL	1
Bacon, BR; Di Bisceglie, AM; Sponseller, CA	1
Chen, MF; Hung, CM; Jeng, LB; Lee, WC; Liaw, YF; Lin, DY; Tan, PP	1
Bruno, R; Filice, C; Filice, G; Sacchi, P	1
Vargas, HE	1
Barbui, AM; Ciancio, A; David, E; Debernardi-Venon, W; Franchello, A; Gentilcore, E; Marzano, A; Negro, F; Piantino, P; Rizzetto, M; Salizzoni, M; Smedile, A	1
Brooks, EA; Lacey, LF; Miller, DW; Payne, SL	1
Bass, NM; Freise, C; Maslow, L; Terrault, NA; Yao, FY	1
Yoshida, EM	1
Aaron, L; Carnot, F; Pialoux, G	1
Hasegawa, K; Hashimoto, E; Hayashi, N; Kanai, N; Naritomi, T; Ogawa, M; Takasaki, K; Taniai, M	1
Merle, P; Trepo, C	1
Pol, S	1
Angelico, M; Araco, A; Casciani, CU; Di Paolo, D; Lionetti, R; Petrolati, A; Tisone, G; Trinito, MO; Zazza, S	1
Kawata, S; Okumoto, K; Saito, T; Shinzawa, H; Sugahara, K; Togashi, H; Watanabe, H	1
Sokal, E	1
Okanoue, T	1
Chou, YP; Lee, CM; Lee, JF; Lu, SN; Wang, JH	1
Bock, CT; Böker, KH; Flemming, P; Glomb, I; Klempnauer, J; Krüger, M; Manns, MP; Tillmann, HL; Trautwein, C	1
Sata, M; Ueno, T	1
Chesky, A; Demetris, AJ; Dodson, FS; Dvorchik, I; Fung, JJ; Gray, E; Joya-Vazquez, PP; Shakil, O; Vargas, HE	1
Cianciara, J; Cybula, A; Jabłońska, J; Nazzal, K; Walencik, G; Łoch, T	1

Reviews

54 review(s) available for lamivudine and Cirrhosis, Liver

Article	Year
Hepatitis Delta: Prevalence, Natural History, and Treatment Options. Gastroenterology clinics of North America, 2020, Volume: 49, Issue:2 Topics: Adenine; Antibodies, Viral; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Global Health; Hepatitis D; Hepatitis delta Antigens; Hepatitis Delta Virus; Humans; Interferon alpha-2; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Organophosphonates; Prevalence; Risk; RNA, Viral; Serologic Tests	2020
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis. Journal of clinical pharmacology, 2014, Volume: 54, Issue:2 Topics: Adenine; Alanine Transaminase; Antiviral Agents; Creatinine; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Randomized Controlled Trials as Topic; Treatment Outcome	2014
Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis. World journal of gastroenterology, 2013, Oct-21, Volume: 19, Issue:39 Topics: Adult; Aged; Antiviral Agents; Bilirubin; Biomarkers; Chi-Square Distribution; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Odds Ratio; Prothrombin Time; Serum Albumin; Serum Albumin, Human; Treatment Outcome; Viral Load	2013
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34 Suppl 1 Topics: Adenine; Administration, Oral; Antiviral Agents; Carcinoma, Hepatocellular; Fibrosis; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Telbivudine; Tenofovir; Thymidine	2014
Impact of HBV therapy on the incidence of hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34 Suppl 1 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Tenofovir	2014
What physicians should know about the management of chronic hepatitis B in children: East side story. World journal of gastroenterology, 2014, 04-07, Volume: 20, Issue:13 Topics: Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Child; Child, Preschool; Diagnostic Errors; Drug Resistance, Viral; Education, Medical, Continuing; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Pediatrics; Treatment Outcome	2014
Management of chronic hepatitis B in children: an unresolved issue. Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:5 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Carrier State; Child; Databases, Bibliographic; Guanine; Hepatitis B, Chronic; Humans; Immune Tolerance; Incidence; Interferons; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Risk; Tenofovir	2014
Management of chronic hepatitis B infection. BMJ (Clinical research ed.), 2015, Oct-21, Volume: 351 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Immunization Programs; Interferons; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Practice Guidelines as Topic; Viral Load	2015
Update on occult hepatitis B virus infection. World journal of gastroenterology, 2016, Oct-21, Volume: 22, Issue:39 Topics: Antiviral Agents; Coinfection; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Interferons; Lamivudine; Liver Cirrhosis; Liver Transplantation; Mutation; Occupational Exposure; Prevalence; Renal Dialysis; RNA Splicing; Viral Load	2016
Treatment of chronic hepatitis B infection: an update of Swedish recommendations. Scandinavian journal of infectious diseases, 2008, Volume: 40, Issue:6-7 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B, Chronic; HIV Infections; Humans; Immunocompromised Host; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Transplantation; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Sweden; Tenofovir	2008
[Entecavir]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7 Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Multicenter Studies as Topic; Organophosphonates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Virus Replication	2008
Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success. Best practice & research. Clinical gastroenterology, 2008, Volume: 22, Issue:6 Topics: Adenine; Adenine Nucleotides; Alanine Transaminase; Carcinoma, Hepatocellular; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Treatment Outcome; Virus Replication	2008
Prevention of hepatocellular carcinoma in hepatitis B virus infection. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:8 Topics: Adolescent; Adult; Antiviral Agents; Asia; Carcinoma, Hepatocellular; Child; Child, Preschool; Disease Progression; DNA, Viral; Drug Resistance, Viral; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunization Programs; Infant; Infant, Newborn; Interferons; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Time Factors; Treatment Outcome; Viral Load; Young Adult	2009
[Anti-viral treatment for liver cirrhosis]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2010, Volume: 107, Issue:1 Topics: Hepatitis B; Hepatitis C; Humans; Interferons; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors	2010
[Prevention for the development of hepatitis B virus-related hepatocellular carcinoma by anti-viral treatment]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 4 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Organophosphonates	2011
Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis. Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:6 Topics: Adenine; Administration, Oral; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome; Viral Load	2012
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. Gastroenterology, 2012, Volume: 142, Issue:6 Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Deoxycytidine; Dideoxynucleosides; Disease Progression; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Diseases; Male; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Pyrrolidinones; Raltegravir Potassium; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Substance Abuse, Intravenous; Tenofovir; Treatment Outcome	2012
A meta-analysis of nucleos(t)ide analogues in patients with decompensated cirrhosis due to hepatitis B. Digestive diseases and sciences, 2013, Volume: 58, Issue:3 Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Nucleosides; Nucleotides; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine	2013
Antiviral treatment of patients with HBV-related cirrhosis. Journal of gastroenterology and hepatology, 2002, Volume: 17 Suppl 3 Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis	2002
Treatment of HBeAg-negative chronic hepatitis B. Seminars in liver disease, 2003, Volume: 23, Issue:1 Topics: Adenine; Antiviral Agents; Endpoint Determination; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Inflammation; Interferon-alpha; Lamivudine; Liver Cirrhosis; Organophosphonates; Patient Care Planning; Prognosis; Reverse Transcriptase Inhibitors; Virus Replication	2003
Management of patients with decompensated HBV cirrhosis. Seminars in liver disease, 2003, Volume: 23, Issue:1 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Drug Resistance; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Organophosphonates; Prognosis; Reverse Transcriptase Inhibitors; Risk Factors	2003
[Drug therapy of hepatitis B and C]. Duodecim; laaketieteellinen aikakauskirja, 2003, Volume: 119, Issue:6 Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin	2003
[Hepatitis: associated diseases. Risk groups -- prevention -- treatment]. Praxis, 2003, Aug-13, Volume: 92, Issue:33 Topics: Adenine; Adult; Antiviral Agents; Child; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Infant; Infant, Newborn; Interferons; Lamivudine; Liver Cirrhosis; Male; Mutation; Organophosphonates; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors	2003
Management of the patient with hepatitis B virus-related cirrhosis. Journal of hepatology, 2003, Volume: 39 Suppl 1 Topics: Adenine; Antiviral Agents; Hepatitis B; Humans; Interferons; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Reverse Transcriptase Inhibitors	2003
Hepatitis B. American family physician, 2004, Jan-01, Volume: 69, Issue:1 Topics: Acute Disease; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Disease Progression; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Mass Screening; Patient Selection; Recombinant Proteins; Reverse Transcriptase Inhibitors; Risk Factors; Sexually Transmitted Diseases; Substance Abuse, Intravenous; United States; Vaccination	2004
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of viral hepatitis, 2004, Volume: 11, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins	2004
Therapeutic advances in chronic hepatitis B. Journal of gastroenterology and hepatology, 2004, Volume: 19 Suppl Topics: Clinical Trials as Topic; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Reverse Transcriptase Inhibitors	2004
Management of hepatitis B in liver transplantation patients. Seminars in liver disease, 2004, Volume: 24 Suppl 1 Topics: Adenine; Antiviral Agents; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Organophosphonates; Reoperation; Secondary Prevention; Virus Replication	2004
Antiviral therapy in patients with chronic hepatitis B and cirrhosis. Gastroenterology clinics of North America, 2004, Volume: 33, Issue:3 Topics: Adenine; Antiviral Agents; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Organophosphonates	2004
Evolving strategies to prevent HBV recurrence. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:10 Suppl 2 Topics: Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis Antibodies; Hepatitis B; Hepatitis B Core Antigens; Hepatitis D; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Preoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention; Survival Analysis; Tissue Donors	2004
[Introduction to chronic hepatitis type B]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8 Topics: Age Factors; Amino Acid Motifs; Antiviral Agents; Disease Progression; Genotype; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver; Liver Cirrhosis; Mutation	2004
[Current status of treatment for HBV-related cirrhosis]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8 Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Interferon-alpha; Interferon-beta; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Risk; Treatment Outcome	2004
[Liver transplantation for hepatitis B virus cirrhosis]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8 Topics: Biomarkers; Brain Death; Combined Modality Therapy; DNA, Viral; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Living Donors; Preoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention	2004
Prevention of hepatocellular carcinoma. Seminars in liver disease, 2005, Volume: 25, Issue:2 Topics: Carcinoma, Hepatocellular; Chemoprevention; Disease Progression; Disease Susceptibility; Hepatitis B; Humans; Interferons; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Reverse Transcriptase Inhibitors; Secondary Prevention; Vaccination	2005
Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis. Hepatobiliary & pancreatic diseases international : HBPD INT, 2006, Volume: 5, Issue:1 Topics: Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome; Virus Replication	2006
[Liver transplantation for complications of hepatitis B]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 2 Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; Guanine; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Mutation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Vaccination; Viral Load; Virus Replication	2006
Lamivudine treatment in patients with chronic hepatitis B and cirrhosis. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:13 Topics: Disease Progression; Drug-Related Side Effects and Adverse Reactions; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis	2006
[Therapy of hepatitis B virus infection]. Praxis, 2006, Sep-06, Volume: 95, Issue:36 Topics: Adenine; Antiviral Agents; Drug Antagonism; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Forecasting; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Organophosphonates; Polyethylene Glycols; Prognosis; Recombinant Proteins; Reverse Transcriptase Inhibitors; Time Factors	2006
[Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient]. Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:10 Pt 2 Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Mutation; Organophosphonates; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors; Treatment Outcome	2006
[Entecavir: a new hope for the treatment of chronic hepatitis B]. Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:5 Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Viremia	2007
Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy. Reviews in gastroenterological disorders, 2007,Spring, Volume: 7, Issue:2 Topics: Adenine; Antiviral Agents; Disease Progression; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Organophosphonates	2007
[Natural course and recommendation of therapy for HBV infection]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2007, Volume: 104, Issue:10 Topics: Antiviral Agents; Biomarkers; Carrier State; DNA, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Risk Factors	2007
Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain. European journal of gastroenterology & hepatology, 2008, Volume: 20, Issue:4 Topics: Adult; Aged; Antiviral Agents; Cost of Illness; Drug Resistance, Viral; Female; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Markov Chains; Middle Aged; Models, Statistical; Spain	2008
Review article: current antiviral therapy of chronic hepatitis B. Alimentary pharmacology & therapeutics, 2008, Volume: 28, Issue:2 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Polyethylene Glycols; Pyrimidinones; Recombinant Proteins; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Virus Replication	2008
Treatment of chronic viral hepatitis. Antiviral chemistry & chemotherapy, 1998, Volume: 9, Issue:6 Topics: 2-Aminopurine; Animals; Antimetabolites; Antiviral Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Therapy, Combination; Ducks; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Animal; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Marmota; Poultry Diseases; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tumor Cells, Cultured	1998
Antiviral therapy of HBV- and HCV-induced liver cirrhosis. Journal of clinical gastroenterology, 2000, Volume: 30, Issue:3 Topics: 2-Aminopurine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; Thymalfasin; Thymosin; Treatment Outcome	2000
Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when? Journal of hepatology, 2000, Volume: 33, Issue:2 Topics: Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Reverse Transcriptase Inhibitors	2000
Hepatitis B immune globulin: the US experience. Clinical transplantation, 2000, Volume: 14 Suppl 2 Topics: Antiviral Agents; Graft Survival; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Incidence; Lamivudine; Liver Cirrhosis; Liver Transplantation; Mutation; Patient Selection; Time Factors; Transplantation, Homologous; Treatment Failure; Treatment Outcome; United States; Virus Replication	2000
Therapeutic management of hepatitis B-related cirrhosis. Journal of viral hepatitis, 2001, Volume: 8, Issue:6 Topics: Antiviral Agents; Controlled Clinical Trials as Topic; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Recombinant Proteins	2001
[HVB and HVC infections in nephrology]. Nephrologie, 2001, Volume: 22, Issue:6 Topics: Antiviral Agents; Comorbidity; Contraindications; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Diseases; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Postoperative Complications; Renal Dialysis; Ribavirin; Vaccination; Viral Hepatitis Vaccines; Viremia	2001
Lamivudine for the treatment of chronic hepatitis B. Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:3 Topics: Antiviral Agents; Child; Clinical Trials as Topic; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Cirrhosis; Liver Transplantation	2002
[Antiviral therapy for liver cirrhosis type B]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2002, Volume: 99, Issue:2 Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Interferons; Japan; Lamivudine; Liver Cirrhosis	2002
[Forefront of therapy for hepatic fibrosis]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2002, Volume: 99, Issue:4 Topics: Animals; Drugs, Chinese Herbal; Genetic Therapy; Glycyrrhizic Acid; Humans; Interferon-alpha; Interferon-beta; Lamivudine; Liver Cirrhosis; Liver Cirrhosis, Experimental; Mice; Rats	2002

Trials

60 trial(s) available for lamivudine and Cirrhosis, Liver

Article	Year
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:13 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Splenomegaly; Thrombocytopenia; Viral Load	2019
Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis. World journal of gastroenterology, 2013, Jun-14, Volume: 19, Issue:22 Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; Chi-Square Distribution; China; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Time Factors; Treatment Outcome; Viral Load	2013
De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis. World journal of gastroenterology, 2013, Oct-07, Volume: 19, Issue:37 Topics: Adenine; Adult; Alanine Transaminase; Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; China; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Prospective Studies; Time Factors; Treatment Outcome	2013
Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:10 Topics: Adenine; Alanine Transaminase; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Organophosphonates; Polymerase Chain Reaction; Treatment Outcome; Ultrasonography; Viral Load	2014
Curative effect of combined lamivudine, adefovir dipivoxil, and stem cell transplantation on decompensated hepatitis B cirrhosis. Genetics and molecular research : GMR, 2014, Feb-21, Volume: 13, Issue:4 Topics: Adenine; alpha-Fetoproteins; Cholinesterases; Combined Modality Therapy; Female; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Organophosphonates; Prothrombin Time; Stem Cell Transplantation	2014
Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis. European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:5 Topics: Adenine; Adult; Antiviral Agents; Cost-Benefit Analysis; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Telbivudine; Thymidine; Treatment Outcome	2016
Long-term lamivudine therapy in chronic hepatitis B. Alimentary pharmacology & therapeutics, 2016, Volume: 44, Issue:4 Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Treatment Outcome; Young Adult	2016
Effect of nucleoside analogues in the treatment of hepatitis B cirrhosis and its effect on Th17 cell. European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:2 Topics: Adenine; Adult; Aged; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Th17 Cells; Treatment Outcome	2017
[Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2008, Volume: 16, Issue:6 Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates	2008
Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis. The American journal of gastroenterology, 2008, Volume: 103, Issue:11 Topics: Adult; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Treatment Outcome	2008
[Telbivudine treatment on cirrhosis resulting from chronic hepatitis B]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:1 Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Nucleosides; Pyrimidinones; Telbivudine; Thymidine; Treatment Outcome; Virus Replication	2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals. AIDS (London, England), 2009, Aug-24, Volume: 23, Issue:13 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cross-Sectional Studies; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Viral Load	2009
[A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:7 Topics: Adenine; Administration, Oral; Adult; Aged; Antiviral Agents; Collagen; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Organophosphonates; Time Factors; Treatment Outcome	2009
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece c Gut, 2011, Volume: 60, Issue:8 Topics: Administration, Oral; Adult; Aged; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Greece; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors	2011
Evaluation of adefovir & lamivudine in chronic hepatitis B: correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis. The Indian journal of medical research, 2011, Volume: 133 Topics: Adenine; Adolescent; Adult; Aged; Alanine Transaminase; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Inflammation; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Pilot Projects; Prospective Studies; Reverse Transcriptase Inhibitors; Young Adult	2011
[One-year combination therapy de novo of adefovir dipivoxil and lamivudine for decompensated cirrhosis related to HBV]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2011, Volume: 25, Issue:2 Topics: Adenine; Adult; Antiviral Agents; China; Drug Therapy, Combination; Female; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Treatment Outcome	2011
Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis. Journal of clinical gastroenterology, 2011, Volume: 45, Issue:9 Topics: Adenine; Aged; Antiviral Agents; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Proportional Hazards Models; Prospective Studies; Risk Factors; Severity of Illness Index; Survival Rate; Treatment Outcome	2011
[Study of xiaozhang recipe combined with lamivudine in treatment of 84 chronic viral hepatitis B patients with compensated liver cirrhosis]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2011, Volume: 31, Issue:9 Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hepatitis B, Chronic; Humans; Integrative Medicine; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Phytotherapy; Prospective Studies; Young Adult	2011
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:4 Topics: Adult; Aged; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Multivariate Analysis; Republic of Korea; Viremia	2012
[Effects of Fuzheng Huayu Capsule on the ratio of TGF-beta1/BMP-7 of chronic viral hepatitis B fibrosis patients of Gan-Shen insufficiency blood-stasis obstruction syndrome]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2012, Volume: 32, Issue:1 Topics: Adult; Antiviral Agents; Bone Morphogenetic Protein 7; Drugs, Chinese Herbal; Female; Hepatitis B, Chronic; Humans; Lamivudine; Leukocytes, Mononuclear; Liver Cirrhosis; Male; Middle Aged; Transforming Growth Factor beta1	2012
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis. Journal of viral hepatitis, 2012, Volume: 19, Issue:10 Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Multicenter Studies as Topic; Nucleosides; Prospective Studies; Pyrimidinones; Severity of Illness Index; Telbivudine; Thymidine; Treatment Outcome; Young Adult	2012
[Efficacy of combination therapy of lamivudine and adefovir dipivoxyl for patients with hepatitis B-induced decompensated liver cirrhosis]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2012, Volume: 37, Issue:12 Topics: Adenine; Adult; Antiviral Agents; Drug Therapy, Combination; End Stage Liver Disease; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates	2012
[Effects of lamivudine on cirrhotic patients following chronic hepatitis B]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:4 Topics: Antiviral Agents; DNA, Viral; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis	2002
Long-term lamivudine therapy for chronic hepatitis B in patients with and without cirrhosis. Pharmacotherapy, 2002, Volume: 22, Issue:10 Topics: Administration, Oral; Adult; Alanine Transaminase; Antiviral Agents; Asian People; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Time Factors	2002
Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation. Transplantation, 2002, Oct-27, Volume: 74, Issue:8 Topics: Alanine Transaminase; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Preoperative Care; Reverse Transcriptase Inhibitors; Severity of Illness Index; Virus Replication; Waiting Lists	2002
Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed. The Journal of infectious diseases, 2002, Dec-15, Volume: 186, Issue:12 Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; HIV Infections; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Tenofovir; Time Factors; Viral Load	2002
[Therapeutic efficacy of lamivudine in patients with hepatitis B virus-related decompensated cirrhosis in Korea]. Taehan Kan Hakhoe chi = The Korean journal of hepatology, 2002, Volume: 8, Issue:4 Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged	2002
Histological outcome during long-term lamivudine therapy. Gastroenterology, 2003, Volume: 124, Issue:1 Topics: Adult; Alanine Transaminase; Disease Progression; DNA, Viral; Drug Administration Schedule; Female; Genetic Variation; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Necrosis; Reverse Transcriptase Inhibitors; Safety	2003
Ineffectiveness of hepatitis B vaccination in lamivudine-treated cirrhotics. Journal of hepatology, 2004, Volume: 40, Issue:2 Topics: Adult; Combined Modality Therapy; Female; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Pilot Projects; Reverse Transcriptase Inhibitors; Treatment Failure	2004
Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation. Hepatobiliary & pancreatic diseases international : HBPD INT, 2004, Volume: 3, Issue:1 Topics: Adult; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Preoperative Care; Reference Values; Secondary Prevention; Transplantation, Homologous; Treatment Outcome	2004
Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B. World journal of gastroenterology, 2004, Sep-15, Volume: 10, Issue:18 Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Matrix Metalloproteinase 1; Middle Aged; Reverse Transcriptase Inhibitors; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance. Journal of viral hepatitis, 2004, Volume: 11, Issue:5 Topics: Adult; Carcinoma, Hepatocellular; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Risk Assessment	2004
Lamivudine for patients with chronic hepatitis B and advanced liver disease. The New England journal of medicine, 2004, Oct-07, Volume: 351, Issue:15 Topics: Adolescent; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Double-Blind Method; Drug Resistance; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Mutation; Prospective Studies; Severity of Illness Index	2004
Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis. Journal of gastroenterology, 2004, Volume: 39, Issue:11 Topics: Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Time Factors	2004
Liver histology of Asian patients with chronic hepatitis B on prolonged lamivudine therapy. Alimentary pharmacology & therapeutics, 2005, Apr-01, Volume: 21, Issue:7 Topics: Adolescent; Adult; Asian People; Biopsy; China; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors	2005
Two-year observation of the clinical efficacy in treating chronic hepatitis B Patients with Ganxian recipe and lamivudine. Chinese journal of integrative medicine, 2005, Volume: 11, Issue:1 Topics: Adolescent; Adult; Female; Gene Frequency; Genes, Viral; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Medicine, Chinese Traditional; Middle Aged; Mutation; Phytotherapy; Plant Preparations; Reverse Transcriptase Inhibitors; Treatment Outcome	2005
Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis. Journal of viral hepatitis, 2005, Volume: 12, Issue:4 Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatic Encephalopathy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Organophosphonates; Survival Analysis; Taiwan	2005
Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhotics. World journal of gastroenterology, 2005, Jul-28, Volume: 11, Issue:28 Topics: Adult; Aged; Drug Resistance, Viral; Female; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome	2005
Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis. Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:10 Topics: Adult; DNA, Viral; Drug Administration Schedule; Female; Follow-Up Studies; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome	2005
Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis. Antiviral therapy, 2005, Volume: 10, Issue:6 Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome	2005
Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus. Journal of Korean medical science, 2005, Volume: 20, Issue:5 Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Antiviral Agents; Drug Combinations; Drug Resistance, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Treatment Outcome	2005
Is lamivudine a safe and effective therapy for patients with chronic hepatitis B and advanced liver disease? Nature clinical practice. Gastroenterology & hepatology, 2005, Volume: 2, Issue:3 Topics: Biopsy; Disease Progression; Double-Blind Method; Follow-Up Studies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Ultrasonography	2005
A study on efficacy of lamivudine therapy in decompensated cirrhosis of liver due to chronic hepatitis B virus infection. Nepal Medical College journal : NMCJ, 2004, Volume: 6, Issue:2 Topics: Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors	2004
Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine. Liver international : official journal of the International Association for the Study of the Liver, 2006, Volume: 26, Issue:4 Topics: Adult; Alanine Transaminase; Antiviral Agents; Biopsy; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Inflammation; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Necrosis; Polyethylene Glycols; Recombinant Proteins	2006
The effectiveness of lamivudine treatment in cirrhotic patients with HBV precore mutations: a prospective, open-label study. Digestive diseases and sciences, 2006, Volume: 51, Issue:7 Topics: Adult; Aged; Antiviral Agents; Biomarkers; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Prospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Survival Analysis; Treatment Outcome; Virus Replication	2006
[The clinical study on chronic hepatitis B treated by the four-step therapeutics of Traditional Chinese Medicine]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2006, Volume: 29, Issue:7 Topics: Adolescent; Adult; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Phytotherapy; Plants, Medicinal; Treatment Outcome	2006
[Clinical and pathological study on effects of Qianggan Capsule combined lamivudine on hepatic fibrosis in patients with chronic hepatitis B]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2006, Volume: 26, Issue:11 Topics: Adult; Capsules; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Phytotherapy; Reverse Transcriptase Inhibitors; Treatment Outcome	2006
[A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2007, Volume: 15, Issue:11 Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates	2007
A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis. Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:5 Topics: Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Time Factors	2008
Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease. Antiviral therapy, 2007, Volume: 12, Issue:8 Topics: Adult; Carcinoma, Hepatocellular; Disease Progression; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome	2007
The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis. Advances in therapy, 2008, Volume: 25, Issue:3 Topics: Adult; Aged; Anti-HIV Agents; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged	2008
Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Gastroenterology, 2008, Volume: 134, Issue:7 Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Circular; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunohistochemistry; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Risk Assessment; Risk Factors; Secondary Prevention; Sequence Analysis, DNA; Time Factors; Treatment Outcome; Viral Load; Virus Replication	2008
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. The New England journal of medicine, 1998, Jul-09, Volume: 339, Issue:2 Topics: Adolescent; Adult; Aged; Alanine Transaminase; DNA, Viral; Double-Blind Method; Drug Administration Schedule; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors	1998
The pharmacokinetics of lamivudine in patients with impaired hepatic function. European journal of clinical pharmacology, 1998, Volume: 54, Issue:4 Topics: Adult; Anti-HIV Agents; Caffeine; Female; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged	1998
Saquinavir therapy in patients with the advanced HIV infection and liver cirrhosis. Japanese journal of infectious diseases, 1999, Volume: 52, Issue:4 Topics: Adult; Drug Therapy, Combination; Hemophilia A; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Liver Cirrhosis; Ritonavir; Saquinavir; Stavudine	1999
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection. Journal of hepatology, 2000, Volume: 33, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Drug Evaluation; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome	2000
Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States. The American journal of managed care, 2001, Volume: 7, Issue:7 Topics: Antiviral Agents; Budgets; Cost-Benefit Analysis; Decision Trees; Disease Progression; Drug Costs; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; United States	2001
Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:1 Topics: Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Treatment Failure; Vaccines, Synthetic	2002
[Lamivudine in patients with chronic HBV infection and therapeutic difficulties]. Polskie Archiwum Medycyny Wewnetrznej, 2002, Volume: 107, Issue:1 Topics: Adult; Aged; Contraindications; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon Type I; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Recombinant Proteins; Virus Replication	2002

Other Studies

181 other study(ies) available for lamivudine and Cirrhosis, Liver

Article	Year
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy. Hepatology international, 2021, Volume: 15, Issue:1 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Prospective Studies; Treatment Outcome	2021
Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis. The American journal of gastroenterology, 2017, Volume: 112, Issue:6 Topics: Adult; Antiviral Agents; Aspartate Aminotransferases; Carcinoma, Hepatocellular; DNA, Viral; Elasticity Imaging Techniques; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prospective Studies; Severity of Illness Index	2017
Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis. European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:9 Topics: Acidosis, Lactic; Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lactic Acid; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Prospective Studies; Risk Factors; Sex Factors; Tenofovir; Time Factors; Treatment Outcome; Up-Regulation; Young Adult	2017
Assessment of histopathological alterations in patients with chronic hepatitis B infection following long-term oral antiviral therapy. Saudi medical journal, 2018, Volume: 39, Issue:10 Topics: Adult; Antiviral Agents; Drug Administration Schedule; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Tenofovir	2018
High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs. Medicine, 2019, Volume: 98, Issue:1 Topics: Adult; alpha-Fetoproteins; Antiviral Agents; Carcinoma, Hepatocellular; Early Detection of Cancer; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Nucleosides; Retrospective Studies; Risk Factors; Telbivudine	2019
Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections. European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:7 Topics: Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Germany; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Viral Load; Young Adult	2019
Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2019, Volume: 29, Issue:4 Topics: Adenine; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; China; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Telbivudine	2019
Long-term prognosis of liver disease in patients with chronic hepatitis B virus infection receiving nucleos(t)ide analogue therapy: an analysis using a Markov chain model. European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:11 Topics: Adenine; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Markov Chains; Middle Aged; Nucleosides; Organophosphonates; Prognosis	2019
Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis. Journal of viral hepatitis, 2013, Volume: 20 Suppl 1 Topics: Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Telbivudine; Thymidine; Treatment Outcome; Young Adult	2013
HBV recurrence lowered by lamivudine/HBIG combination therapy in liver transplant patients: ten-year experience. Hepatobiliary & pancreatic diseases international : HBPD INT, 2013, Volume: 12, Issue:2 Topics: Adult; Aged; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; DNA, Viral; End Stage Liver Disease; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Secondary Prevention; Survival Analysis; Time Factors; Treatment Outcome	2013
Prognosis of 153 patients with decompensated hepatitis B virus-related cirrhosis is improved after 3-year continuous lamivudine treatment. Chinese medical journal, 2013, Volume: 126, Issue:8 Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Prognosis; Retrospective Studies	2013
[Treatment of one advanced schistosomiasis patient with hepatitis B cirrhosis by lamivudine and adefovir dipivoxil]. Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control, 2013, Volume: 25, Issue:1 Topics: Adenine; Adult; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Organophosphonates; Schistosomiasis	2013
Sharp bounds on causal effects using a surrogate endpoint. Statistics in medicine, 2013, Nov-10, Volume: 32, Issue:25 Topics: Antiviral Agents; Biomarkers; Biometry; Causality; Cohort Studies; Confounding Factors, Epidemiologic; Drug Therapy, Combination; Hepatitis B e Antigens; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Observation; Probability; Randomized Controlled Trials as Topic; Research Design; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome	2013
The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2013, Volume: 58, Issue:1 Topics: Adult; Antiviral Agents; Cohort Studies; Female; Genotype; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Plasma; Prevalence; Prognosis; Serbia; Survival Analysis; Time Factors; Treatment Outcome; Viral Load	2013
Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients. Clinical and molecular hepatology, 2013, Volume: 19, Issue:3 Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Organophosphonates; Retrospective Studies; Treatment Outcome	2013
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability. Gut, 2014, Volume: 63, Issue:8 Topics: Adult; Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Time Factors	2014
Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea. Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:5 Topics: Adult; Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Republic of Korea; Telbivudine; Thymidine; Time Factors; Treatment Outcome	2014
Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection. Clinical and experimental immunology, 2014, Volume: 176, Issue:1 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Immunohistochemistry; Lamivudine; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Phosphorylation; Protein Isoforms; Signal Transduction; Smad3 Protein; Telbivudine; Thymidine; Treatment Outcome; Young Adult	2014
[Loss of hbs antigen after treatment with analogues: infrequent but stable and beneficial]. La Revue du praticien, 2013, Volume: 63, Issue:10 Topics: Antiviral Agents; Asian People; Carcinoma, Hepatocellular; Cohort Studies; Guanine; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Prognosis; Republic of Korea; Treatment Outcome	2013
[Relationship between effect of lamivudine in the treatment of cirrhotic patients with uncompensated hepatitis B with HBV genotypes and cytotoxic T lymphocyte]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2013, Volume: 27, Issue:4 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; T-Lymphocytes, Cytotoxic	2013
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease. Gut, 2014, Volume: 63, Issue:12 Topics: Adult; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Kaplan-Meier Estimate; Lamivudine; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Patient Acuity; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Time	2014
Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus. Clinical and molecular hepatology, 2014, Volume: 20, Issue:2 Topics: Adenine; Adult; Aged; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Odds Ratio; Organophosphonates; Retrospective Studies; Severity of Illness Index; Survival Rate	2014
Antiviral therapy of chronic hepatitis B. Intervirology, 2014, Volume: 57, Issue:3-4 Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Gene Products, pol; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Liver Neoplasms; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Telbivudine; Tenofovir; Thymidine; Treatment Outcome; Virus Replication	2014
Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B. Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:2 Topics: Adult; Antiviral Agents; Biomarkers; Biopsy; Disease Progression; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Severity of Illness Index; Time Factors	2015
The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy. Alimentary pharmacology & therapeutics, 2014, Volume: 40, Issue:11-12 Topics: Adenine; Adult; Antiviral Agents; Canada; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Nucleosides; Organophosphonates; Retrospective Studies; Risk Factors; Telbivudine; Tenofovir; Thymidine	2014
[Effects of oral antiviral agents on long-term outcomes of treatment-naive patients with HBV-related decompensated cirrhosis: a retrospective cohort study]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2014, Volume: 22, Issue:11 Topics: Administration, Oral; Antiviral Agents; Cohort Studies; Coinfection; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Retrospective Studies; Treatment Outcome	2014
Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:8 Topics: Adult; Antiviral Agents; Cohort Studies; Comorbidity; Disease Progression; Female; France; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Reference Values; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Tenofovir; Treatment Outcome	2015
Response-guided treatment of cirrhotic chronic hepatitis B patients: multicenter prospective study. World journal of gastroenterology, 2015, Jan-14, Volume: 21, Issue:2 Topics: Adenine; Adult; Antiviral Agents; Biomarkers; China; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Organophosphonates; Prospective Studies; Time Factors; Treatment Outcome; Viral Load	2015
High incidence of lamivudine-resistance-associated vaccine-escape HBV mutants among HIV-coinfected patients on prolonged antiretroviral therapy. Antiviral therapy, 2015, Volume: 20, Issue:5 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans; India; Lamivudine; Liver Cirrhosis; Reverse Transcriptase Inhibitors; Viral Load	2015
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients. Clinical and molecular hepatology, 2015, Volume: 21, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Nucleotides; Retrospective Studies; Tenofovir; Treatment Outcome	2015
Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Sep-15, Volume: 61, Issue:6 Topics: Adult; Africa South of the Sahara; Antiviral Agents; Coinfection; Cross-Sectional Studies; Elasticity Imaging Techniques; Female; Ghana; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Tenofovir; Treatment Outcome; Viral Load	2015
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study. Journal of hepatology, 2015, Volume: 63, Issue:5 Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Elasticity Imaging Techniques; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Follow-Up Studies; Forecasting; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Italy; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Nucleosides; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; Tenofovir	2015
Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis. Digestive diseases (Basel, Switzerland), 2015, Volume: 33, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Tenofovir	2015
Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy. World journal of gastroenterology, 2015, Aug-28, Volume: 21, Issue:32 Topics: Adult; Antiviral Agents; Biopsy; Chi-Square Distribution; China; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Viral Load	2015
Long-term follow-up of HBsAg-positive patients in Germany. European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:1 Topics: Adenine; Adult; Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Mass Screening; Middle Aged; Organophosphonates; Prognosis; Prospective Studies; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Time Factors; Turkey	2016
Long-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study. World journal of gastroenterology, 2015, Dec-14, Volume: 21, Issue:46 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; China; Drug Administration Schedule; Drug Resistance, Viral; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Propensity Score; Prospective Studies; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome; Viral Load; Young Adult	2015
Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients. Acta medica Okayama, 2016, Volume: 70, Issue:1 Topics: Age Factors; Antiviral Agents; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Reverse Transcriptase Inhibitors	2016
Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis. Clinical and experimental medicine, 2017, Volume: 17, Issue:2 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug-Related Side Effects and Adverse Reactions; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Retrospective Studies; Seroconversion; Telbivudine; Thymidine; Treatment Outcome; Viral Load	2017
Subclinical Ascites Does Not Affect the Long-term Prognosis in Hepatitis B Virus-related Cirrhosis Patients Receiving Antivirals. Journal of clinical gastroenterology, 2016, Volume: 50, Issue:8 Topics: Adult; Antiviral Agents; Ascites; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Prognosis; Prothrombin Time; Retrospective Studies; Serum Albumin	2016
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma. Gut and liver, 2016, Nov-15, Volume: 10, Issue:6 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Propensity Score; Retrospective Studies; Risk Factors; Treatment Outcome	2016
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2016, Volume: 14, Issue:11 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Elasticity Imaging Techniques; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Propensity Score; Retrospective Studies; Treatment Outcome	2016
Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5 Topics: Adenine; Adult; Antiviral Agents; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome; Withholding Treatment; Young Adult	2016
[A retrospective study on the liver pathological characteristics and the effect of antiviral treatment for 1 to 7 years old children with heptitis B e antigen negative chronic hepatitis B]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2016, Volume: 54, Issue:8 Topics: Alanine Transaminase; Antiviral Agents; Biopsy; Child; Child, Preschool; Female; Genotype; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Cirrhosis; Male; Retrospective Studies	2016
Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection. Gut, 2018, Volume: 67, Issue:2 Topics: Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Asymptomatic Infections; Carcinoma, Hepatocellular; Culture Media, Conditioned; DNA, Viral; Female; Gene Expression; Genotype; Guanine; Hep G2 Cells; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HT29 Cells; Humans; Interferons; Interleukins; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Polymorphism, Genetic; Recombinant Proteins; Tenofovir; Up-Regulation; Young Adult	2018
New diagnostic tools of hepatitis virus-related liver diseases. Preface. Intervirology, 2008, Volume: 51 Suppl 1 Topics: Antiviral Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Diagnosis, Differential; Drug Resistance, Viral; Elasticity Imaging Techniques; Ferric Compounds; Hepatitis B virus; Hepatitis, Viral, Human; Humans; Iron; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Oxides; Tomography, X-Ray Computed	2008
Regression of cirrhosis of the liver detected by elastiometry. Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:11 Topics: Adult; Antiviral Agents; Biopsy, Needle; Elasticity Imaging Techniques; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Remission Induction; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome	2008
Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment. Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:12 Topics: Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Middle Aged	2008
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure. Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:3 Topics: Adenine; Adult; Aged; Alanine Transaminase; Cohort Studies; Drug Resistance; Female; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Retrospective Studies	2009
[A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus]. The Korean journal of hepatology, 2008, Volume: 14, Issue:3 Topics: Absorptiometry, Photon; Adenine; Adult; Antiviral Agents; Bone Density; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Hypophosphatemia; Lamivudine; Liver Cirrhosis; Male; Organophosphonates; Tomography, X-Ray Computed	2008
[Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:10 Topics: Adult; Aged; Amino Acid Motifs; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence	2008
Core promoter mutant HBV non-responding to adefovir after viral breakthrough on lamivudine: rapid virologic response to tenofovir plus lamivudine in a cirrhotic patient. European journal of medical research, 2008, Oct-27, Volume: 13, Issue:10 Topics: Adenine; DNA, Viral; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Organophosphonates; Promoter Regions, Genetic; Tenofovir	2008
[Evaluation of the effect of living donor liver transplantation on the treatment of severe hepatitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Follow-Up Studies; Hepatitis B; Humans; Immunoglobulins; Immunosuppressive Agents; Kidney Function Tests; Lamivudine; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Postoperative Period; Treatment Outcome; Young Adult	2009
Salvage therapy with tenofovir followed by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare. Le infezioni in medicina, 2009, Volume: 17, Issue:2 Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Salvage Therapy; Tenofovir; Viremia	2009
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension. Journal of hepatology, 2009, Volume: 51, Issue:3 Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; alpha-Fetoproteins; Antiviral Agents; Biomarkers; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Hypertension, Portal; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Prognosis; Prospective Studies; Treatment Outcome	2009
Clinical outcome of lamivudine-resistant chronic hepatitis B patients with compensated cirrhosis under adefovir salvage treatment. Importance of HCC surveillance. European journal of internal medicine, 2009, Volume: 20, Issue:5 Topics: Adenine; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Resistance, Viral; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Retrospective Studies; Treatment Outcome	2009
[Pharmacoeconomic evaluation of telbivudine vs. lamivudine in treating the patients with HBeAg-positive and negative chronic hepatitis B]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:8 Topics: Adult; Antifungal Agents; China; Cost-Benefit Analysis; DNA, Viral; Drug Costs; Economics, Pharmaceutical; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Insurance, Long-Term Care; Lamivudine; Liver Cirrhosis; Male; Markov Chains; Middle Aged; Models, Economic; Nucleosides; Prescription Drugs; Pyrimidinones; Quality-Adjusted Life Years; Telbivudine; Thymidine	2009
Hepatitis B in HIV patients: what is the current treatment and what are the challenges? Journal of HIV therapy, 2009, Volume: 14, Issue:1 Topics: Adenine; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Polyethylene Glycols; Pyrimidinones; Recombinant Proteins; Telbivudine; Tenofovir; Thymidine; Transaminases	2009
[Protocol for the antiviral therapy of hepatitis B and D]. Orvosi hetilap, 2010, Jan-03, Volume: 151, Issue:1 Topics: Adenine; Antiviral Agents; Biopsy; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis D; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Liver Cirrhosis; Nucleotides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir	2010
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:5 Topics: Adult; Aged; Antiviral Agents; Graft Survival; Hepatitis; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Immunoglobulins; Immunologic Deficiency Syndromes; Infections; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Virus Diseases; Viruses	2010
Risk assessment for the development of hepatocellular carcinoma: according to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease. Journal of hepatology, 2010, Volume: 53, Issue:1 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Case-Control Studies; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Mutation; Retrospective Studies; Risk Assessment; Time Factors; Young Adult	2010
Does chemotherapy prevent HBV-related hepatocellular carcinoma? Pros. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42 Suppl 3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Chemoprevention; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Nucleotides; Polyethylene Glycols; Recombinant Proteins	2010
Does chemotherapy prevent HBV-related hepatocellular carcinoma? Cons. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42 Suppl 3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Chemoprevention; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Nucleosides; Nucleotides; Polyethylene Glycols; Primary Prevention; Recombinant Proteins; Selection Bias; Tertiary Prevention	2010
Accelerated progression of hepatocellular carcinoma with cytokeratin 19 expression during treatment with lamivudine for hepatitis B virus-related liver cirrhosis. Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:2 Topics: Carcinoma, Hepatocellular; Disease Progression; Fatal Outcome; Hepatitis B virus; Humans; Keratin-19; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged	2011
[Treatment has a positive impact on the long-term evolution of chronic hepatitis B]. Gastroenterologie clinique et biologique, 2010, Volume: 34 Suppl 2 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir	2010
[Key points of nursing HbeAg negative cirrhotic patients with nucleot (s) ide analogues antiviral therapy]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2010, Volume: 24, Issue:3 Topics: Adult; Aged; Antiviral Agents; Breast Feeding; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Mortality; Nucleosides; Nursing Care; Weights and Measures	2010
Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation. Minerva medica, 2010, Volume: 101, Issue:6 Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Injections, Intravenous; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prohibitins; Prospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention	2010
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence. Journal of hepatology, 2011, Volume: 55, Issue:3 Topics: Adult; Aged; Antibiotic Prophylaxis; Antiviral Agents; DNA, Circular; DNA, Viral; Female; Follow-Up Studies; Hepacivirus; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Immunologic Factors; Lamivudine; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Secondary Prevention	2011
Predictive factors for the response to lamivudine in HBV-infected patients with chronic hepatitis and cirrhosis. The Tokai journal of experimental and clinical medicine, 2006, Sep-20, Volume: 31, Issue:3 Topics: Adult; Cohort Studies; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome	2006
Non-response to previous interferon therapy and cirrhosis are risk factors for predicting breakthrough during lamivudine therapy in patients with chronic hepatitis B. The Tokai journal of experimental and clinical medicine, 2010, Sep-20, Volume: 35, Issue:3 Topics: Adult; Alanine Transaminase; Antiviral Agents; Disease Progression; Female; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Risk Factors; Treatment Failure; Viral Load	2010
Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs. Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:6 Topics: Adenine; Adult; Elasticity Imaging Techniques; Female; Hepatitis B; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors	2011
Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma? Gut, 2011, Volume: 60, Issue:8 Topics: Carcinoma, Hepatocellular; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male	2011
[New insight for HBV DNA and HBsAg quantitation during antiviral therapy in patients with chronic hepatitis B]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 57, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Pyrimidinones; Telbivudine; Thymidine	2011
High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-on. Digestive diseases and sciences, 2012, Volume: 57, Issue:2 Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Treatment Failure; Viral Load; Virus Replication	2012
Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. BMC cancer, 2011, Sep-21, Volume: 11 Topics: Adult; Age Factors; Aged; Antiviral Agents; Base Sequence; Carcinoma, Hepatocellular; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Molecular Sequence Data; Mutation; Nucleic Acid Amplification Techniques; Retrospective Studies; Risk Factors	2011
Canadian patients with chronic hepatitis B cannot access appropriate drug treatments: a call for change. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2011, Volume: 25, Issue:10 Topics: Adenine; Antiviral Agents; Canada; Drug Approval; Guanine; Health Services Accessibility; Hepatitis B, Chronic; Humans; Insurance Coverage; Lamivudine; Liver Cirrhosis; National Health Programs; Organophosphonates; Tenofovir	2011
Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B? Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:12 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Female; Guanine; Hepatectomy; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male	2011
Economic analysis between entecavir and lamivudine for the treatment of chronic hepatitis B in Hong Kong. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:7 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cost-Benefit Analysis; DNA, Viral; Drug Costs; Drug Resistance, Viral; Guanine; Health Care Costs; Hepatitis B virus; Hepatitis B, Chronic; Hong Kong; Hospitals, Public; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Quality-Adjusted Life Years; Viral Load	2012
Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:10 Topics: Administration, Oral; Adult; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Nucleotides; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Load	2012
Treatment effects on patient-important outcomes can be small, even with large effects on surrogate markers. Journal of clinical epidemiology, 2012, Volume: 65, Issue:9 Topics: Biomarkers; Hepatitis B; Hepatitis B e Antigens; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors	2012
Lamivudine treatment enabling right hepatectomy for hepatocellular carcinoma in decompensated cirrhosis. World journal of gastroenterology, 2012, May-28, Volume: 18, Issue:20 Topics: Aged; Carcinoma, Hepatocellular; Hepatectomy; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Reverse Transcriptase Inhibitors	2012
Clinical prediction of failure of Lamivudine prophylaxis for hepatitis B virus-infected patients undergoing cytotoxic chemotherapy for malignancy. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prognosis; Rituximab; Survival Rate; Treatment Failure; Viral Load	2012
Can long term therapy with oral nucleos(t)ide analogs influence the prognosis of chronic hepatitis B-related complications? Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:10 Topics: Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Nucleotides	2012
Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013, Volume: 11, Issue:1 Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Blood Chemical Analysis; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome; Turkey	2013
A case of hepatitis B reactivation due to the hepatitis B virus escape mutant in a patient undergoing chemotherapy. Virologica Sinica, 2012, Volume: 27, Issue:6 Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immune Evasion; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Mutation, Missense	2012
Recent progress and new trends in the treatment of hepatitis B. Journal of medical virology, 2002, Volume: 67, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms	2002
[HBV cirrhosis]. Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:5 Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence	2002
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. Journal of medical virology, 2002, Volume: 68, Issue:2 Topics: Adult; Amino Acid Motifs; Amino Acid Sequence; Antiviral Agents; Base Sequence; DNA, Viral; Drug Resistance, Viral; Female; Genes, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence	2002
Histological improvement with lamivudine therapy for de novo hepatitis B occurring in an anti-HBs-positive child after bone marrow transplantation. Bone marrow transplantation, 2002, Volume: 30, Issue:7 Topics: Adolescent; Antibodies, Viral; Bone Marrow Transplantation; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Leukemia, Myeloid, Acute; Liver Cirrhosis; Virus Activation	2002
Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B. International journal of molecular medicine, 2002, Volume: 10, Issue:5 Topics: Antiviral Agents; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Recurrence	2002
[Effects of lamivudine on cirrhotic patients following chronic hepatitis B]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:5 Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis	2002
[Efficacy and safety of long-term lamivudine therapy in the patients with decompensated liver cirrhosis secondary to hepatitis B]. Taehan Kan Hakhoe chi = The Korean journal of hepatology, 2002, Volume: 8, Issue:4 Topics: Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Treatment Outcome	2002
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2003, Volume: 9, Issue:1 Topics: Adult; Aged; Alanine Transaminase; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; United States	2003
A renal allograft recipient with viral-burden, steatoviral, and fibroviral hepatitis B who achieved remission with Lamivudine. Journal of clinical gastroenterology, 2003, Volume: 36, Issue:2 Topics: Adult; Alanine Transaminase; DNA, Viral; Fatty Liver; gamma-Glutamyltransferase; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Male; Remission Induction; Reverse Transcriptase Inhibitors; Transplantation, Homologous	2003
Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2003, Volume: 9, Issue:2 Topics: Adenine; Adult; Antiviral Agents; Bacterial Infections; Cholestasis; Drug Resistance, Microbial; Fibrosis; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Organophosphonates; Peritonitis; Recurrence; Renal Insufficiency; Reverse Transcriptase Inhibitors	2003
Virological and histological outcome of a patient with chronic hepatitis B transplanted with liver from hepatitis C virus-positive donor. Transplantation proceedings, 2003, Volume: 35, Issue:1 Topics: Adult; Antiviral Agents; Cadaver; Carcinoma, Hepatocellular; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Tissue Donors	2003
[Genotyping of hepatitis B virus and clinical investigation]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2002, Volume: 16, Issue:4 Topics: Adult; Antiviral Agents; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Treatment Outcome	2002
[One year and half treatment with lamivudine in active cirrhosis resulting from chronic hepatitis B]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2003, Volume: 11, Issue:3 Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Treatment Outcome; Virus Replication	2003
Decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine allowing surgery for hepatocellular carcinoma. Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:5 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Hepatectomy; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Radiography	2003
Effect of long-term lamivudine therapy on histological outcome in chronic hepatitis B. Gastroenterology, 2003, Volume: 125, Issue:4 Topics: Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Reverse Transcriptase Inhibitors; Treatment Outcome	2003
[Liver histological changes after lamivudine treating in chronic hepatitis B patients with HBeAg positive]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2003, Volume: 11, Issue:9 Topics: Adolescent; Adult; Antiviral Agents; Child; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male	2003
Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus. AIDS patient care and STDs, 2003, Volume: 17, Issue:9 Topics: Adenine; Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Organophosphonates; Organophosphorus Compounds; Tenofovir	2003
Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection. The American journal of gastroenterology, 2004, Volume: 99, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Rate; Treatment Outcome	2004
Management of decompensated HBV cirrhosis: lamivudine and beyond. The American journal of gastroenterology, 2004, Volume: 99, Issue:1 Topics: Antiviral Agents; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Survival Rate	2004
Lamivudine therapy for decompensated liver cirrhosis related to hepatitis B virus infection. Intervirology, 2003, Volume: 46, Issue:6 Topics: Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Transplantation; Reverse Transcriptase Inhibitors; Severity of Illness Index	2003
[Therapeutic effect of lamivudine on liver fibrosis resulted from chronic hepatitis B]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2003, Volume: 11, Issue:12 Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis	2003
Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated. Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:1 Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Living Donors; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors	2004
Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:4 Topics: Adenine; Adult; Antiviral Agents; Cholestasis, Intrahepatic; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Organophosphonates; Promoter Regions, Genetic; Reoperation; Treatment Outcome	2004
The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B. Journal of gastroenterology, 2004, Volume: 39, Issue:3 Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartic Acid; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Methionine; Middle Aged; Mutation; Predictive Value of Tests; Retrospective Studies; Treatment Outcome; Tyrosine	2004
Reversibility of cirrhosis in chronic hepatitis B. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004, Volume: 2, Issue:4 Topics: Adult; Antiviral Agents; Biopsy, Needle; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Immunohistochemistry; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Recombinant Proteins; Remission, Spontaneous; Sampling Studies; Severity of Illness Index; Treatment Outcome	2004
[A case of liver cirrhosis B resistant to lamivudine showing the clinical effect of adefovir dipivoxil]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2004, Volume: 101, Issue:5 Topics: Adenine; Amino Acid Motifs; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Treatment Outcome	2004
Regression of cirrhosis associated with hepatitis B e (HBe) antigen-negative chronic hepatitis B infection with prolonged lamivudine therapy. European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:3 Topics: Adult; DNA, Viral; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Long-Term Care; Male; Reverse Transcriptase Inhibitors	2004
Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2004, Volume: 17, Issue:10 Topics: Anti-HIV Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Green Fluorescent Proteins; Hepatitis B, Chronic; Humans; Immunohistochemistry; Interferons; Isoenzymes; Lamivudine; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Membrane Proteins; Microscopy, Fluorescence; Plasmids; Prostaglandin-Endoperoxide Synthases; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trans-Activators; Transfection; Viral Regulatory and Accessory Proteins	2004
Lamivudine induced stable reversal in HBV liver cirrhosis Child C: a case report. Hepato-gastroenterology, 2003, Volume: 50 Suppl 2 Topics: Adult; Alanine Transaminase; Female; Hepatitis B, Chronic; Humans; Hyperbilirubinemia; Lamivudine; Liver Cirrhosis; Prothrombin Time; Reverse Transcriptase Inhibitors; Serum Albumin	2003
Lamivudine treatment in patients with hepatitis B virus induced liver cirrhosis. Hepato-gastroenterology, 2003, Volume: 50 Suppl 2 Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; DNA, Viral; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors; Serum Albumin; Treatment Outcome	2003
Successful treatment by lamivudine and regular hemodialysis in a patient with decompensated hepatitis B virus-related cirrhosis complicated by terminal renal impairment. Journal of clinical gastroenterology, 2004, Volume: 38, Issue:9 Topics: Anti-HIV Agents; Hepatitis B, Chronic; Humans; Kidney Failure, Chronic; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Renal Dialysis; Treatment Outcome	2004
[Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2004, Volume: 12, Issue:10 Topics: Adolescent; Adult; Aged; Amino Acid Motifs; Antiviral Agents; Child; Child, Preschool; DNA-Directed DNA Polymerase; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation	2004
Tenofovir therapy for lamivudine resistance following liver transplantation. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:12 Topics: Adenine; Adult; Antiviral Agents; Chronic Disease; Drug Resistance, Viral; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Salvage Therapy; Tenofovir; Treatment Outcome	2004
Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. Journal of clinical immunology, 2004, Volume: 24, Issue:6 Topics: Adult; Blood Cell Count; Case-Control Studies; CD8-Positive T-Lymphocytes; Cross Infection; Dendritic Cells; Female; Hepatitis B; Humans; Immunity, Innate; Immunocompromised Host; Interferon-alpha; Killer Cells, Natural; Lamivudine; Leukocytes, Mononuclear; Liver Cirrhosis; Male; Middle Aged; Virus Replication	2004
[Ambulatory management of hepatitis B before and after liver transplantation]. Deutsche medizinische Wochenschrift (1946), 2005, Jan-28, Volume: 130, Issue:4 Topics: Ambulatory Care; Antiviral Agents; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunization, Passive; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Care; Premedication; Preoperative Care; Secondary Prevention	2005
[Lamivudine treatment of patients with decompensated HBV cirrhosis and mutation in YMDD motif]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2005, Volume: 13, Issue:1 Topics: Amino Acid Motifs; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Point Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase	2005
[Liver transplantation finally available also for our patients with chronic hepatitis B virus infection]. Vnitrni lekarstvi, 2004, Volume: 50, Issue:12 Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Recurrence	2004
[Liver transplantation for chronic hepatitis B]. Vnitrni lekarstvi, 2004, Volume: 50, Issue:12 Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Recurrence	2004
[Liver transplantation for hepatitis B]. Vnitrni lekarstvi, 2004, Volume: 50, Issue:12 Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Secondary Prevention	2004
Virological and biochemical relapse after discontinuation of lamivudine monotherapy for chronic hepatitis B in Japan: comparison with breakthrough hepatitis during long-term treatment. Intervirology, 2005, Volume: 48, Issue:2-3 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Bilirubin; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Promoter Regions, Genetic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome	2005
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2005, Volume: 11, Issue:5 Topics: Adenine; Adult; Antibodies, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Phenotype; Retrospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention	2005
Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma. Oncology reports, 2005, Volume: 13, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; Treatment Outcome	2005
Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B. Clinical transplantation, 2005, Volume: 19, Issue:3 Topics: Antiviral Agents; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Treatment Outcome	2005
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy. Antiviral therapy, 2005, Volume: 10, Issue:3 Topics: Adult; Aged; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Virus Replication	2005
Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results. Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:7 Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Waiting Lists	2005
[Efficacy and safety of adefovir dipivoxil in patients with decompensated liver cirrhosis with Lamivudine resistance compared to patients with compensated liver disease]. The Korean journal of hepatology, 2005, Volume: 11, Issue:2 Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates	2005
Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance. Journal of viral hepatitis, 2005, Volume: 12, Issue:4 Topics: Alanine Transaminase; Amino Acid Substitution; Antiviral Agents; Canada; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation, Missense; Retrospective Studies; Sequence Analysis, DNA; Treatment Outcome	2005
[A preliminary study on the serum HBsAg level in patients with chronic hepatitis B and hepatitis cirrhosis during lamivudine therapy]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2005, Volume: 13, Issue:8 Topics: Adolescent; Adult; Antiviral Agents; Female; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged	2005
The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Alimentary pharmacology & therapeutics, 2005, Sep-01, Volume: 22, Issue:5 Topics: Adult; Breath Tests; Caffeine; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome	2005
Liver transplantation for patients with hepatitis B virus-related diseases. Zhonghua wai ke za zhi [Chinese journal of surgery], 2001, Volume: 39, Issue:10 Topics: Antiviral Agents; Combined Modality Therapy; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure, Acute; Liver Neoplasms; Liver Transplantation; Male; Secondary Prevention; Survival Rate	2001
[Adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD mutation]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2005, Volume: 34, Issue:5 Topics: Adenine; Adult; Aged; Amino Acid Motifs; Antiviral Agents; DNA-Directed DNA Polymerase; Female; Hepatic Encephalopathy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Organophosphonates; Protein Structure, Tertiary; Recurrence; Reverse Transcription	2005
Remission of hepatitis B virus-associated membranoproliferative glomerulonephritis in a cirrhotic patient after lamivudine therapy. Clinical nephrology, 2006, Volume: 65, Issue:3 Topics: Administration, Oral; Adult; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Remission Induction; Reverse Transcriptase Inhibitors; RNA, Viral	2006
Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal. Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:2 Topics: Bone Marrow Transplantation; Fatal Outcome; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Multiple Myeloma; Renal Insufficiency; Reverse Transcriptase Inhibitors; Sepsis; Virus Activation	2006
Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis. Journal of viral hepatitis, 2006, Volume: 13, Issue:4 Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Bilirubin; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Serum Albumin; Statistics, Nonparametric	2006
[Relationship between Shenzhen HBV genotype and precore/core promoter mutation and antiviral effects]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2006, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Promoter Regions, Genetic; Treatment Outcome; Viral Core Proteins; Young Adult	2006
Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient. American journal of hematology, 2006, Volume: 81, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Viral; Fatal Outcome; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Lymphoma, Follicular; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Virus Activation	2006
Sustained clinical improvement of a patient with decompensated hepatitis B virus-related cirrhosis after treatment with lamivudine monotherapy. The Tohoku journal of experimental medicine, 2006, Volume: 210, Issue:1 Topics: Anti-HIV Agents; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Middle Aged; Treatment Outcome; Viral Load	2006
Prevention of mortality from hepatitis B and hepatitis C. Lancet (London, England), 2006, Sep-09, Volume: 368, Issue:9539 Topics: Carcinoma, Hepatocellular; Female; Hepatitis B; Hepatitis C, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Liver Cirrhosis; Liver Neoplasms	2006
Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors. Clinical therapeutics, 2006, Volume: 28, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Models, Theoretical; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Severity of Illness Index; Survival Analysis; Taiwan; Virus Replication	2006
Decompensated lamivudine-resistant hepatitis B virus-related cirrhosis treated successfully with adefovir dipivoxil allowing surgery for hepatocellular carcinoma. Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:7 Topics: Adenine; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Disease Progression; Drug Resistance, Viral; Follow-Up Studies; Hepatectomy; Hepatitis B, Chronic; Humans; Immunohistochemistry; Lamivudine; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Risk Assessment; Severity of Illness Index; Treatment Outcome	2007
Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital. Journal of the National Medical Association, 2007, Volume: 99, Issue:4 Topics: Adenine; Adolescent; Adult; Black or African American; Contraindications; Female; Hepatitis B, Chronic; Hispanic or Latino; Hospitals, Urban; Humans; Insurance Coverage; Interferons; Lamivudine; Liver Cirrhosis; Male; Mass Screening; Middle Aged; New York City; Organophosphonates; Patient Compliance; Pilot Projects; Refusal to Treat; Risk Factors; Urban Health; Utilization Review	2007
Treatment of chronic hepatitis B with lamivudine in renal transplant recipients. The International journal of artificial organs, 2007, Volume: 30, Issue:4 Topics: Adult; Alanine Transaminase; Antiviral Agents; Biopsy; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Immunosuppression Therapy; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Remission Induction; Renal Dialysis; Reverse Transcriptase Inhibitors; Time Factors; Viremia	2007
Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B. Journal of medical virology, 2007, Volume: 79, Issue:9 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Interferon-beta; Japan; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies	2007
Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis. Alimentary pharmacology & therapeutics, 2007, Aug-01, Volume: 26, Issue:3 Topics: Carcinoma, Hepatocellular; Cost-Benefit Analysis; DNA, Viral; Female; Hepatitis B virus; Humans; Lamivudine; Life Expectancy; Liver Cirrhosis; Liver Neoplasms; Male; Models, Theoretical; Reverse Transcriptase Inhibitors; Risk Factors	2007
[New German and American guidelines for therapy of hepatitis B. Discrepancies and similarities]. Medizinische Klinik (Munich, Germany : 1983), 2007, Sep-15, Volume: 102, Issue:9 Topics: Adenine; Alanine Transaminase; Antiviral Agents; Biopsy; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Germany; Guanine; Hepatitis B; Humans; Lamivudine; Liver; Liver Cirrhosis; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Telbivudine; Thymidine; United States	2007
Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation. Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome	2007
Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection. Journal of clinical microbiology, 2007, Volume: 45, Issue:12 Topics: Adult; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Guanine; Hepatitis B Core Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Luminescent Measurements; Male; Middle Aged; Necrosis; Statistics as Topic	2007
[Predictive factors of hepatitis B virus DNA negative conversion among patients with chronic hepatitis B during lamivudine therapy]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2007, Volume: 21, Issue:3 Topics: Adult; DNA, Viral; Female; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Proportional Hazards Models; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Young Adult	2007
Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:6 Topics: Adenine; Adult; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome	2008
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients. Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:7 Topics: Adolescent; Adult; Aged; Alanine Transaminase; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Young Adult	2008
Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation, 1996, Nov-27, Volume: 62, Issue:10 Topics: Adult; Female; Hepatitis B; Hepatitis, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Male; Middle Aged; Neural Conduction; Pilot Projects; Treatment Outcome; Virus Replication	1996
Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation, 1997, Feb-15, Volume: 63, Issue:3 Topics: Adult; Chronic Disease; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence	1997
Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis. The American journal of gastroenterology, 1997, Volume: 92, Issue:9 Topics: Aged; Anti-HIV Agents; Ascites; Drug Combinations; Hepatitis B; Hepatitis, Chronic; HIV Infections; Humans; Jaundice; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Reverse Transcriptase Inhibitors; Stavudine	1997
Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation. Digestive diseases and sciences, 1998, Volume: 43, Issue:6 Topics: Acute Disease; Bilirubin; DNA, Viral; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Transaminases	1998
Treatment of chronic hepatitis B infection. The New England journal of medicine, 1998, Jul-09, Volume: 339, Issue:2 Topics: Carcinoma, Hepatocellular; DNA, Viral; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Reverse Transcriptase Inhibitors	1998
Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:5 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Liver Cirrhosis; Reverse Transcriptase Inhibitors; Stavudine	1998
Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation. The American journal of gastroenterology, 1999, Volume: 94, Issue:3 Topics: Antiviral Agents; DNA, Viral; Drug Evaluation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Point Mutation; Recurrence; Virus Replication	1999
Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis? Journal of gastroenterology and hepatology, 1999, Volume: 14 Suppl Topics: Adolescent; Adult; Asian People; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B e Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Methylprednisolone; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Survival Rate	1999
Association of lamivudine resistance in recurrent hepatitis B after liver transplantation with advanced hepatic fibrosis. Transplantation, 1999, Jul-27, Volume: 68, Issue:2 Topics: Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence; Treatment Outcome	1999
Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine. Transplant international : official journal of the European Society for Organ Transplantation, 1999, Volume: 12, Issue:4 Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Follow-Up Studies; Genetic Variation; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Renal Dialysis; Sequence Deletion	1999
Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection. Transplantation proceedings, 1999, Volume: 31, Issue:6 Topics: Adult; Aged; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors	1999
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:1 Topics: Bilirubin; DNA, Viral; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Rate; Treatment Outcome; Virus Replication	2000
Extension of transplantation free time by lamivudine in patients with hepatitis B-induced decompensated cirrhosis. Transplantation, 2000, Jun-15, Volume: 69, Issue:11 Topics: Adult; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Preoperative Care; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Virus Replication	2000
Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. Journal of hepatology, 2000, Volume: 33, Issue:2 Topics: Administration, Oral; Adult; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome	2000
Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:6 Topics: Aged; Antiviral Agents; Biopsy; DNA, Viral; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Severity of Illness Index; Virus Replication	2000
Liver transplantation in Chinese patients with chronic hepatitis B. Transplantation proceedings, 2000, Volume: 32, Issue:7 Topics: Antiviral Agents; Asian People; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Retrospective Studies; Survival Rate; Taiwan; Time Factors	2000
Acute liver failure during lamivudine treatment in a hepatitis B cirrhotic patient. The American journal of gastroenterology, 2001, Volume: 96, Issue:1 Topics: Drug Administration Schedule; Fatal Outcome; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure, Acute; Long-Term Care; Male; Middle Aged; Recurrence; Treatment Failure	2001
The real danger of lamivudine-resistant hepatitis B virus infection in the immunocompromised host. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:3 Topics: Antiviral Agents; Chronic Disease; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications	2001
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. Journal of hepatology, 2001, Volume: 34, Issue:6 Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence	2001
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:2 Topics: Adolescent; Adult; Aged; Cohort Studies; DNA, Viral; Drug Resistance; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Severity of Illness Index; Survival Analysis; Virus Replication; Waiting Lists	2001
Efficacy of lamivudine in decompensated cirrhosis secondary to hepatitis B: cautious optimism in the war not yet won. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2001, Volume: 15, Issue:7 Topics: Antiviral Agents; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis	2001
[HIV-HBV coinfection and the liver]. Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:5 Topics: Biopsy; Didanosine; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Ritonavir; Saquinavir; Stavudine	2001
Living-related partial liver transplantation for decompensated hepatitis B without reactivation of hepatitis B in the following 30 months. Journal of gastroenterology, 2001, Volume: 36, Issue:9 Topics: Adult; Antibodies; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Living Donors; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Secondary Prevention	2001
Lamivudine and rapid regeneration of the atrophic liver in decompensated cirrhosis due to hepatitis B. The American journal of gastroenterology, 2002, Volume: 97, Issue:2 Topics: Atrophy; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Function Tests; Liver Regeneration; Male; Middle Aged; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2002
Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis. Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:3 Topics: Base Sequence; DNA, Viral; Drug Resistance, Microbial; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors	2002
Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis. The American journal of gastroenterology, 2002, Volume: 97, Issue:3 Topics: Cholestasis; Hepatitis; Humans; Lamivudine; Liver; Liver Cirrhosis; Liver Transplantation; Reverse Transcriptase Inhibitors; Viral Load	2002
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation, 2002, May-27, Volume: 73, Issue:10 Topics: Adult; Aged; Alkaline Phosphatase; Antiviral Agents; Disease-Free Survival; Female; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunoglobulins; Lamivudine; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome	2002